Paper10469748
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
Rebbeck TR and 14 others. J Natl Cancer Inst, 1999. Cited by 479 papers, by iCite.
Cite this record
ConductScience Library. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. Papers, record 10469748. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10469748
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Genes, BRCA1 | Major topic |
| Mutation | Major topic |
| Ovariectomy | Major topic |
| Age Factors | |
| Case-Control Studies | |
| Estrogen Replacement Therapy | |
| Female | |
| Heterozygote | |
| Humans | |
| Odds Ratio | |
| Registries | |
| Risk | |
| Surveys and Questionnaires | |
| Time Factors |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA57601 | NCI NIH HHS | United States | R01CA057601 | PubMed and NIH | NIH RePORTER |
| CA74415 | NCI NIH HHS | United States | R01CA074415 | PubMed and NIH | NIH RePORTER |
| P30CA16520 | NCI NIH HHS | United States | P30CA016520 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 10469738 | Bad news/good news: information about breast cancer risk following prophylactic oophorectomy. | https://conductscience.org/library/papers/10469738 |
Source PubMed
Cited by105
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 479 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42130632 | Hereditary cancer syndromes with gynecological cancer risk: focus on prevention strategies. | Front Oncol | 2026 | https://conductscience.org/library/papers/42130632 | PubMed |
| 41811390 | Impact of Ethnicity on the Uptake of Risk Reducing Mastectomy in Unaffected BRCA1/2 and PALB2 Carriers in Canada. | Ann Surg Oncol | 2026 | https://conductscience.org/library/papers/41811390 | PubMed |
| 40243654 | Understanding Susceptibility to Breast Cancer: From Risk Factors to Prevention Strategies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40243654 | PubMed |
| 40226594 | Premature ovarian insufficiency and the risk of breast cancer. | Hum Reprod Open | 2025 | https://conductscience.org/library/papers/40226594 | PubMed |
| 40025950 | Thirty Years of BRCA1: Mechanistic Insights and Their Impact on Mutation Carriers. | Cancer Discov | 2025 | https://conductscience.org/library/papers/40025950 | PubMed |
| 38817104 | Basic knowledge for counseling patients undergoing risk-reducing salpingo-oophorectomy. | Obstet Gynecol Sci | 2024 | https://conductscience.org/library/papers/38817104 | PubMed |
| 38672070 | Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery. | Biomedicines | 2024 | https://conductscience.org/library/papers/38672070 | PubMed |
| 38112915 | Contraception as chemoprevention of ovarian cancer in BRCA1 and BRCA2 women. | Hormones (Athens) | 2024 | https://conductscience.org/library/papers/38112915 | PubMed |
| 37254150 | Progesterone from ovulatory menstrual cycles is an important cause of breast cancer. | Breast Cancer Res | 2023 | https://conductscience.org/library/papers/37254150 | PubMed |
| 36900415 | Breast Cancer Risk and Breast-Cancer-Specific Mortality following Risk-Reducing Salpingo-Oophorectomy in BRCA Carriers: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36900415 | PubMed |
| 36637775 | Hormone replacement therapy in BRCA mutation carriers: how shall we do no harm? | Hormones (Athens) | 2023 | https://conductscience.org/library/papers/36637775 | PubMed |
| 36614207 | The Role of Hormonal Replacement Therapy in BRCA Mutated Patients: Lights and Shadows. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36614207 | PubMed |
| 35402908 | Machine-learning of complex evolutionary signals improves classification of SNVs. | NAR Genom Bioinform | 2022 | https://conductscience.org/library/papers/35402908 | PubMed |
| 34348913 | Bilateral Salpingo-oophorectomy and Breast Cancer Risk for BRCA1 and BRCA2 Mutation Carriers: Assessing the Evidence. | Cancer Prev Res (Phila) | 2021 | https://conductscience.org/library/papers/34348913 | PubMed |
| 33885953 | Hormone replacement therapy in BRCA mutation carriers and risk of ovarian, endometrial, and breast cancer: a systematic review. | J Cancer Res Clin Oncol | 2021 | https://conductscience.org/library/papers/33885953 | PubMed |
| 33010199 | BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study. | J Genet Couns | 2021 | https://conductscience.org/library/papers/33010199 | PubMed |
| 31170278 | Performance of the Gail and Tyrer-Cuzick breast cancer risk assessment models in women screened in a primary care setting with the FHS-7 questionnaire. | Genet Mol Biol | 2019 | https://conductscience.org/library/papers/31170278 | PubMed |
| 30883986 | A randomized controlled intervention to promote readiness to genetic counseling for breast cancer survivors. | Psychooncology | 2019 | https://conductscience.org/library/papers/30883986 | PubMed |
| 30787204 | Towards a more precise and individualized assessment of breast cancer risk. | Aging (Albany NY) | 2019 | https://conductscience.org/library/papers/30787204 | PubMed |
| 30222235 | Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial. | BJOG | 2019 | https://conductscience.org/library/papers/30222235 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10469748
GET https://conductscience.org/api/papers/v1/10469748/cited_by?page=2